🇺🇸 FDA
Patent

US 8685403

Insulin-like growth factor signaling and integrin

granted A61KA61K2039/505A61K38/12

Quick answer

US patent 8685403 (Insulin-like growth factor signaling and integrin) held by The Regents of the University of California expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2039/505, A61K38/12, A61P, A61P35/00